Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones

scientific article

Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030420327
P356DOI10.1186/BCR921
P3181OpenCitations bibliographic resource ID3853744
P932PMC publication ID549181
P698PubMed publication ID15318928
P5875ResearchGate publication ID8392526

P50authorWalter C. WillettQ1133904
Graham ColditzQ5592728
Susan E. HankinsonQ76570836
P2860cites workRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationQ28137833
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast CancerQ28142158
Epidemiology of non-steroidal anti-inflammatory drugs and cancerQ28196393
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal typesQ28238049
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisQ28258638
Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?Q72010719
Incidence of female breast cancer among atomic bomb survivors, 1950-1985Q72421675
Dietary fat and sports activity as determinants for age at menarcheQ72892941
Genetics of breast cancerQ73004105
Hereditary breast cancerQ74333329
Caloric restriction and incidence of breast cancerQ79755892
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesQ28280957
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyQ28283241
Proportion of breast cancer cases in the United States explained by well-established risk factorsQ28283778
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenQ29396434
Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.Q30620197
Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the diseaseQ30705774
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseQ30747351
In-utero and early life exposures in relation to risk of breast cancerQ33806874
Is estradiol a genotoxic mutagenic carcinogen?Q33851357
Optimal diets for prevention of coronary heart diseaseQ34160163
The causes and prevention of cancerQ34204331
Strategy of prevention: lessons from cardiovascular disease.Q34782046
The role of prolactin in mammary carcinomaQ35067253
Exposures in Childhood, Adolescence and Early Adulthood and Breast Cancer Risk: a Systematic Review of the LiteratureQ35119030
Aromatase inhibitors for chemopreventionQ35612327
Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countriesQ36134335
Pre-eclampsia in pregnancy and subsequent risk for breast cancerQ36624347
Hypothesis: does breast cancer originate in utero?Q37584827
Migration patterns and breast cancer risk in Asian-American womenQ39403629
A review of the epidemiology of human breast cancerQ39858364
Endogenous hormones as a major factor in human cancer.Q40333832
Reproductive factors and breast cancerQ40862181
Recreational and occupational physical activities and risk of breast cancerQ40871354
Breast cancer risk associated with proliferative breast disease and atypical hyperplasiaQ40877771
The aetiology and pathogenesis of human breast cancerQ40933353
Increased cell division as a cause of human cancerQ41202194
Folate: effects on carcinogenesis and the potential for cancer chemoprevention.Q41255116
Toward a unified concept of mammary carcinogenesisQ41435007
Serum hormones and the alcohol-breast cancer association in postmenopausal womenQ43595452
Breast Cancer Mortality Among Immigrants in Australia and CanadaQ43804050
Serum estradiol level and risk of breast cancer during treatment with raloxifeneQ43846631
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studiesQ43963634
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trialQ44146948
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer riskQ44507925
Risk factors for breast cancer according to estrogen and progesterone receptor statusQ44753983
Pooled analysis of prospective cohort studies on height, weight, and breast cancer riskQ47229226
Dual effects of weight and weight gain on breast cancer riskQ47300501
Mammographic features and breast cancer risk: effects with time, age, and menopause statusQ50594567
Is Estradiol a Genotoxic Mutagenic Carcinogen?1Q55982485
Leisure physical activity and age at menarcheQ56636030
A Prospective Study of Folate Intake and the Risk of Breast CancerQ57750801
Transient Increase in the Risk of Breast Cancer after Giving BirthQ59265488
A unifying concept of the aetiology of breast cancerQ68347227
Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyQ69396132
Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosisQ69759118
Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal womenQ70672621
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
breast neoplasmQ23929670
P304page(s)213-8
P577publication date2004-08-06
P1433published inBreast Cancer ResearchQ2208481
P1476titleTowards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones
P478volume6

Reverse relations

cites work (P2860)
Q36245897A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study
Q37440908A Prospective Study of the Relationship between Psychological Factors and Breast Cancer
Q38030881A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative.
Q36250581A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population
Q44067192Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues.
Q37341393Age at menopause and determinants of hysterectomy and menopause in a multi-ethnic community: the Hilo Women's Health Study
Q35971618An immunohistochemical method to study breast cancer cell subpopulations and their growth regulation by hormones in three-dimensional cultures
Q38818614Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells
Q36738668Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
Q92331020Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study
Q37212023Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects
Q33778852Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies
Q36507427Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies
Q54208544Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.
Q45184299Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study
Q43893904Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent
Q58762425Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling
Q37585095Biological determinants of endocrine resistance in breast cancer
Q40447587Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.
Q33708123Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
Q33418922Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
Q37861636Breast cancer prevention based on gene-environment interaction
Q36924721Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
Q34559145Circulating sex hormones and mammographic breast density among postmenopausal women
Q35659606Circulating sex steroids and breast cancer risk in premenopausal women
Q43103606Control of mammary stem cell function by steroid hormone signalling.
Q35571951Convergence and divergence of genetic and modular networks between diabetes and breast cancer
Q26751985Diet and risk of breast cancer
Q37848467Dietary modification for women after breast cancer treatment: a narrative review
Q57142283Early breast cancer
Q36919219Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk
Q26768636Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room
Q27023016Estrogen, male dominance and esophageal adenocarcinoma: is there a link?
Q36113238Exogenous estrogen protects mice from the consequences of obesity and alcohol
Q38664941Experience of menopause in aboriginal women: a systematic review
Q37052900Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women
Q38024316Folate and breast cancer: what about high-risk women?
Q33882180GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast
Q35023058Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines
Q35139194Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women
Q87107296Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India
Q44660334Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study
Q41874946Healthy lifestyle and risk of breast cancer for indigenous and non-indigenous women in New Zealand: a case control study
Q33555270Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis
Q43581949Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women
Q51789346How estrogen fuels breast cancer.
Q44010610Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women
Q36631628Increased long-term recreational physical activity is associated with older age at natural menopause among heavy smokers: the California Teachers Study
Q37077775Ingested Nitrate and Breast Cancer in the Spanish Multicase-Control Study on Cancer (MCC-Spain).
Q38080039Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies
Q37367067Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial
Q39855627Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.
Q90464089MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
Q90434304Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women
Q36508076Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.
Q27025094Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution
Q37598444Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies
Q38036917MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications
Q34576381Murine Mammary Epithelial Stem Cells: Discovery, Function, and Current Status
Q49795581Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer
Q38081505Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer
Q33779337Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.
Q26861053Plant sterols as anticancer nutrients: evidence for their role in breast cancer
Q37408124Policy and research recommendations emerging from the scientific evidence connecting environmental factors and breast cancer
Q40541957Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change
Q37392711Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature
Q35784828Progesterone regulation of stem and progenitor cells in normal and malignant breast
Q37306276Proportion of invasive breast cancer attributable to risk factors modifiable after menopause
Q89256873Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid
Q90165902Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer
Q39649230Reproductive factors related to childbearing and mammographic breast density.
Q36051449Risk assessment: controversies and management of moderate- to high-risk individuals
Q37052561Serum factors and clinical characteristics associated with serum E-screen activity
Q51652478Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.
Q57106904Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Q36477382Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996
Q89777911Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies
Q26772042Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives
Q36680104Soy isoflavone extracts stimulate the growth of nude mouse xenografts bearing estrogen-dependent human breast cancer cells (MCF-7).
Q37408121State of the evidence: the connection between breast cancer and the environment
Q26799113Steroid hormones, steroid receptors, and breast cancer stem cells
Q35558923Stress and breast cancer: from epidemiology to molecular biology
Q35202536The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics
Q35263089The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology
Q36481375The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2/NEU and Cytokeratin 8/18 and 5/6 in Invasive Breast Carcinoma
Q37033301The PI3K inhibitor taselisib overcomes letrozole resistance in a breast cancer model expressing aromatase
Q35868802The biology of progesterone receptor in the normal mammary gland and in breast cancer
Q35874242The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition
Q37903655The different roles of ER subtypes in cancer biology and therapy
Q37690092Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
Q58803134Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study
Q38080937Triple negative breast cancer in a male-to-female transsexual
Q36077410Understanding breast cancer risk -- where do we stand in 2005?
Q43158472Unraveling genes, hormones, and breast cancer
Q39373643Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review
Q36267669Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence
Q34038195Vegetable protein and vegetable fat intakes in pre-adolescent and adolescent girls, and risk for benign breast disease in young women
Q36126413Zinc and cancer: implications for LIV-1 in breast cancer

Search more.